Crossmark

Characteristics of Anticancer Drugs Approved Under the Accelerated Approval Program in the US: Success or Failure in Converting to Regular Approval

Published Online: 2024-01-04

Published Print: 2024-03

Authors

Oda, Yoshihiro https://orcid.org/0000-0001-6364-9075
Narukawa, Mamoru
License Information

Text and Data Mining valid from 2024-01-04

Version of Record valid from 2024-01-04
More Information

Article History

Received: 3 October 2023

Accepted: 1 December 2023

First Online: 4 January 2024

Declarations

:

: The authors declare no conflict of interest. YO is an employee of Chugai Pharmaceutical Co., Ltd.

Document is current